Glaukos (GKOS) Profit After Tax Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.02% |
| Dec 31, 2025 | -61.96% |
| Sep 30, 2025 | 16.19% |
| Jun 30, 2025 | 24.42% |
| Mar 31, 2025 | -75.17% |
| Dec 31, 2024 | -15.36% |
| Sep 30, 2024 | -75.83% |
| Jun 30, 2024 | -42.46% |
| Mar 31, 2024 | -35.35% |
| Dec 31, 2023 | -51.16% |
| Sep 30, 2023 | -24.57% |
| Jun 30, 2023 | 6.31% |
| Mar 31, 2023 | 13.80% |
| Dec 31, 2022 | -41.95% |
| Sep 30, 2022 | -26.86% |
| Jun 30, 2022 | -93.26% |
| Mar 31, 2022 | 81.78% |
| Dec 31, 2021 | -142.69% |
| Sep 30, 2021 | 43.27% |
| Jun 30, 2021 | -47.95% |
| Mar 31, 2021 | -82.46% |
| Dec 31, 2020 | -132.60% |
| Sep 30, 2020 | -140.35% |
| Jun 30, 2020 | -129.48% |
| Mar 31, 2020 | -299.10% |
| Dec 31, 2019 | 548.71% |
| Sep 30, 2019 | -139.01% |
| Jun 30, 2019 | -67.57% |
| Mar 31, 2019 | -51.77% |
| Dec 31, 2018 | 40.56% |
| Sep 30, 2018 | -47.65% |
| Jun 30, 2018 | 45.04% |
| Mar 31, 2018 | -41.05% |
| Dec 31, 2017 | 30.42% |
| Sep 30, 2017 | 42.44% |
| Jun 30, 2017 | -9.80% |
| Mar 31, 2017 | 30.49% |